Clinically significant changes in genes and variants associated with epilepsy over time: implications for re-analysis

Area of Science:

• Genomics
• Epilepsy Research
• Clinical Diagnostics

Background:

• Many epilepsy patients lack molecular diagnoses despite advances in genetic understanding.
• Re-analysis of existing genomic data is crucial for increasing diagnostic yields.
• Current re-analysis triggers often rely on time elapsed rather than new scientific discoveries.

Purpose of the Study:

• To develop and evaluate a method for tracking changes in clinically relevant genetic information over time.
• To assess the impact of evolving genetic knowledge on re-analysis strategies for epilepsy.
• To provide empirical data for optimizing genomic data re-analysis in clinical practice.

Main Methods:

• Developed Vigelint, a pipeline integrating data from PanelApp and ClinVar.
• Characterized changes in clinically relevant genes and variants over time.
• Applied Vigelint to five clinical-grade epilepsy gene panels.

Main Results:

• Observed highly variable patterns in the availability of new, clinically relevant genetic knowledge.
• Demonstrated that the rate of knowledge accumulation differs significantly across epilepsy panels.
• Highlighted the potential for dynamic, knowledge-driven re-analysis approaches.

Conclusions:

• A dynamic approach to re-analyzing genomic data is likely to benefit epilepsy diagnosis and treatment.
• Vigelint can provide valuable data to guide condition-specific re-analysis strategies.
• Optimizing genomic data re-analysis is essential for maximizing diagnostic yield in epilepsy.